Interestingly, HSP90 overexpression has been observed in numerous cancers, including breast, urinary, ovarian, lung, colon, esophageal, ovarian, endometrial, bone, and prostate cancers [10,11]. This evidence concerns the gene HSP90AA1 and prostate carcinoma.